• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计、合成及二硫代氨基甲酸盐衍生物作为 SARS-CoV-2 M 抑制剂的生物评估。

Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS-CoV-2 M inhibitors.

机构信息

School of Chemical Engineering and Pharmacy, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Key Laboratory for Green Chemical Process of Ministry of Education, Wuhan Institute of Technology, Wuhan 430205, China.

School of Chemical Engineering and Pharmacy, Hubei Key Laboratory of Novel Reactor and Green Chemical Technology, Key Laboratory for Green Chemical Process of Ministry of Education, Wuhan Institute of Technology, Wuhan 430205, China.

出版信息

Bioorg Med Chem Lett. 2024 Dec 1;114:130011. doi: 10.1016/j.bmcl.2024.130011. Epub 2024 Oct 30.

DOI:10.1016/j.bmcl.2024.130011
PMID:39486486
Abstract

SARS-CoV-2 continues to mutate, spread, and impact public health and daily life. The main protease (M) is essential for the replication and maturation of SARS-CoV-2, making it an ideal target for anti-coronaviral drug discovery and development due to its high conservation and lack of homologous proteases in humans. Herein, we designed and synthesized a series of dithiocarbamate derivatives as potent SARS-CoV-2 M inhibitors. Notably, compound L2 exhibited an IC value of 9.1 ± 2.0 nM against SARS-CoV-2 M, underscoring its potential as a promising candidate for anti-coronaviral therapy and justifying further research and development.

摘要

SARS-CoV-2 持续发生突变、传播,并影响公共卫生和日常生活。主蛋白酶(M)对于 SARS-CoV-2 的复制和成熟至关重要,由于其高度保守性和人体内缺乏同源蛋白酶,使其成为抗冠状病毒药物发现和开发的理想靶点。在此,我们设计并合成了一系列二硫代氨基甲酸盐衍生物,作为有效的 SARS-CoV-2 M 抑制剂。值得注意的是,化合物 L2 对 SARS-CoV-2 M 的 IC 值为 9.1±2.0 nM,突出了其作为一种有前途的抗冠状病毒治疗候选药物的潜力,值得进一步研究和开发。

相似文献

1
Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS-CoV-2 M inhibitors.设计、合成及二硫代氨基甲酸盐衍生物作为 SARS-CoV-2 M 抑制剂的生物评估。
Bioorg Med Chem Lett. 2024 Dec 1;114:130011. doi: 10.1016/j.bmcl.2024.130011. Epub 2024 Oct 30.
2
Discovery of highly potent SARS-CoV-2 M inhibitors based on benzoisothiazolone scaffold.基于苯并异噻唑酮骨架发现高效的 SARS-CoV-2 M 抑制剂。
Bioorg Med Chem Lett. 2022 Feb 15;58:128526. doi: 10.1016/j.bmcl.2022.128526. Epub 2022 Jan 5.
3
Discovery of meisoindigo derivatives as noncovalent and orally available M inhibitors: their therapeutic implications in the treatment of COVID-19.发现美索吲哚衍生物作为非共价和口服有效的 M 抑制剂:它们在治疗 COVID-19 中的治疗意义。
Eur J Med Chem. 2024 Jul 5;273:116498. doi: 10.1016/j.ejmech.2024.116498. Epub 2024 May 16.
4
Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M) of SARS-CoV-2.维甲酰萘醌 A 片段衍生物作为抗严重急性呼吸综合征冠状病毒 2 主蛋白酶 (M) 的潜在治疗先导物的构效关系 (SAR) 和分子动力学研究。
J Mol Model. 2021 Feb 28;27(3):97. doi: 10.1007/s00894-021-04703-6.
5
Discovery of a Highly Promising Disulfide Derivative Scaffold as Inhibitor of SARS-CoV-2 Main Protease.发现一种很有前途的二硫键衍生物支架,可作为 SARS-CoV-2 主蛋白酶抑制剂。
Chem Biodivers. 2024 Nov;21(11):e202401034. doi: 10.1002/cbdv.202401034. Epub 2024 Sep 25.
6
Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review.针对 SARS-CoV-2 主蛋白酶的非肽类抑制剂:综述。
Bioorg Chem. 2024 Jun;147:107380. doi: 10.1016/j.bioorg.2024.107380. Epub 2024 Apr 16.
7
SARS-CoV-2 M: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors.SARS-CoV-2 M:肽模拟物和小分子抑制剂的潜在靶标。
Biomolecules. 2021 Apr 19;11(4):607. doi: 10.3390/biom11040607.
8
Discovery of novel oxazole-based macrocycles as anti-coronaviral agents targeting SARS-CoV-2 main protease.发现新型噁唑大环化合物作为靶向 SARS-CoV-2 主蛋白酶的抗冠状病毒药物。
Bioorg Chem. 2021 Nov;116:105363. doi: 10.1016/j.bioorg.2021.105363. Epub 2021 Sep 17.
9
Proposal of novel natural inhibitors of severe acute respiratory syndrome coronavirus 2 main protease: Molecular docking and ab initio fragment molecular orbital calculations.新型严重急性呼吸综合征冠状病毒 2 主蛋白酶天然抑制剂的提出:分子对接和从头算片段分子轨道计算。
Biophys Chem. 2021 Aug;275:106608. doi: 10.1016/j.bpc.2021.106608. Epub 2021 Apr 29.
10
Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors.非甾体抗炎药的氯吡啶酯类化合物及相关衍生物作为强效 SARS-CoV-2 3CL 蛋白酶抑制剂。
Molecules. 2021 Sep 24;26(19):5782. doi: 10.3390/molecules26195782.